Alzheimer's Drug Discovery Foundation
57 West 57th Street
Suite 904
New York
New York
10019
United States
Website: http://www.alzdiscovery.org/
91 articles about Alzheimer's Drug Discovery Foundation
-
The Alzheimer's Drug Discovery Foundation and The Association for Frontotemporal Degeneration Invite Proposals for 2021 Treat FTD Fund
12/15/2020
The Association for Frontotemporal Degeneration (AFTD) and the Alzheimer's Drug Discovery Foundation (ADDF) issued a joint request for proposals (RFP) targeting novel research to advance and accelerate ways to diagnose and treat frontotempora
-
Alzheimer's Drug Discovery Foundation (ADDF) Awards Dr. Jerri M. Rook Esteemed Melvin R. Goodes Prize
11/4/2020
ADDF recognizes Dr. Rook's significant contributions toward advancing novel therapeutics that hold promise for treating Alzheimer's and other central nervous system disorders
-
Breakthrough Moment for Alzheimer's Disease: First Blood Test Comes to Clinic
10/29/2020
Alzheimer's Drug Discovery Foundation's Funding Played Instrumental Role in Helping C2N Diagnostics Develop Test
-
Alzheimer's Drug Discovery Foundation Announces Major Funding Commitment to Validate an Amyloid Blood Test for Non-Invasive Early Detection of Alzheimer's Disease
9/23/2020
C2N Diagnostics' PrecivityADTM blood test carries an FDA Breakthrough Device Designation; earlier studies report test is highly reliable in predicting presence of brain amyloid [23-September-2020] NEW YORK , Sept. 23, 2020 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded more than $2.2 million to C 2 N Diagnosti
-
Alzheimer's Drug Discovery Foundation (ADDF) Announces New Biobank Sharing Program to Accelerate Alzheimer's Disease Biomarker Research
7/22/2020
- ADDF's Diagnostics Accelerator partners with leading pharmaceutical companies to provide access to valuable patient samples collected from earlier clinical trials to qualified researchers for biomarker development - ADDF also announces three new research awards, expanding the Diagnostics Accelerator's investments to almost $16 million across the world [22-July-2020]
-
The Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute to Support Promising Research with Potential to Delay Onset or Slow Progression of Alzheimer's Disease
7/8/2020
The Alzheimer's Drug Discovery Foundation (ADDF) and Harrington Discovery Institute at University Hospitals have granted Eugenia Trushina , Ph.D., of Mayo Clinic Rochester, the ADDF-Harrington Sch
-
Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator Announces First Digital Biomarker Research Award and Data Sharing Platform
4/29/2020
- Digital biomarker awards support technology solutions for early detection of Alzheimer's and related dementias - Data platform enables researchers using digital tools to share their findings for benchmarking, analysis and use across research projects - ADDF's Diagnostics Accelerator has $50 million in commitments from leading philanthropists Leonard A. Lauder, Bill Gates, Jeff Bezos and MacKenzie Bezos, the Dolby family, the Charles and Helen Schwab Foundation,
-
Vaccinex Announces $3 Million Award from the Alzheimer’s Drug Discovery Foundation
12/10/2019
Pepinemab (VX15), an experimental Vaccinex drug previously shown to prevent reduced brain glucose transport in Huntington’s disease, will be tested for similar effects in Alzheimer’s disease
-
Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator Announces Second Round of Awards
12/4/2019
$50 million global research initiative, funded by Leonard A. Lauder, Bill Gates, Jeff and MacKenzie Bezos, among other leading philanthropists, targets resources to speed up development of blood, digital and other biomarkers for early detection of Alzheimer's disease and related dementias.
-
What is the best way to prevent or even reverse Alzheimer’s disease? That’s the question at the top of many researchers’ minds, especially given all of the recent large Phase 3 failures involving beta-amyloid targeting drugs, the most pursued target to date. This is troubling but not entirely sho...
-
Dr. Jeffrey Cummings Wins Alzheimer's Drug Discovery Foundation's (ADDF) Prestigious Melvin R. Goodes Prize
9/17/2019
Dr. Jeffrey Cummings, a world-renowned Alzheimer's researcher and leader in clinical trials, has been named the recipient of the 2019 Melvin R. Goodes Prize for Excellence in Alzheimer's Drug Discovery.
-
The Alzheimer's Drug Discovery Foundation (ADDF) Announces the Final Program of Its 20th International Conference on Alzheimer's Drug Discovery
8/8/2019
The 20th International Conference on Alzheimer's Drug Discovery, a two-day interdisciplinary forum to be held September 16-17, 2019 in Jersey City, NJ, will bring together 20 top researchers to present a diversity of approaches and the latest on innovative treatments and diagnostics for Alzheimer's disease, related dementias and cognitive aging.
-
One problem facing researchers in Alzheimer’s disease is the lack of really good diagnostic tests. Earlier this year, Bill Gates, Jeff Bezos and MacKenzie Bezos teamed to donate over $20 million to the Diagnostics Accelerator, part of the Alzheimer's Drug Discovery Foundation (ADDF).
-
Bill Gates, Jeff Bezos and MacKenzie Bezos have teamed to donate over $20 million to the Diagnostics Accelerator, a project that is part of the Alzheimer's Drug Discovery Foundation (ADDF).
-
Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Invite Applications for 2019 ADDF-Harrington Scholar Award
2/19/2019
The 2019 award is targeting proteostasis and other novel approaches
-
19th Annual Conference on Alzheimer's Drug Discovery Highlights Multiple Approaches to Prevent and Treat Alzheimer's Disease
9/20/2018
Nearly 200 academic and industry researchers gathered this week to share updates on preclinical and clinical-stage Alzheimer's disease research at the 19th International Conference on Alzheimer's Drug Discovery.
-
Dr. Michela Gallagher Wins Alzheimer's Drug Discovery Foundation's Prestigious Melvin R. Goodes Prize
9/17/2018
- Prize recognizes Dr. Gallagher's contributions in the field of Alzheimer's research in academia and through her groundbreaking therapeutics company, AgeneBio
-
New Coalition of Philanthropists Including Bill Gates and Leonard Lauder Commit More Than $30 Million to Develop New Tools to Diagnose Alzheimer's Disease
7/17/2018
Philanthropist Bill Gates and the Alzheimer's Drug Discovery Foundation (ADDF) co-founder Leonard Lauder have announced a new initiative, Diagnostics Accelerator, to develop novel biomarkers for the early detection of Alzheimer's disease and related dementias.
-
Alzheimer's Drug Discovery Foundation And Pfizer's Centers For Therapeutic Innovation Co-Fund New Alzheimer's Project
10/3/2017
-
AgeneBio Receives Grant From Alzheimer's Drug Discovery Foundation For Drug-Discovery Program To Delay The Onset Of Alzheimer's Dementia
7/5/2017